首页> 外文期刊>Peptides: An International Journal >Time-dependent expression of renal vaso-regulatory molecules in LPS-induced endotoxemia in rat.
【24h】

Time-dependent expression of renal vaso-regulatory molecules in LPS-induced endotoxemia in rat.

机译:肾脏血管调节分子在LPS诱导的大鼠内毒素血症中的时间依赖性表达。

获取原文
获取原文并翻译 | 示例
       

摘要

To elucidate roles of microvascular factors in the pathogenesis of renal complications during endotoxemia, that is characterized by renal vasoconstriction and systemic hypotension/generalized non-renal vasodilation, we profile the expression pattern and time-course of three key vaso-regulators, namely endothelin (ET)-1, nitric oxide (NO), and angiotensin II (Ang II). We hypothesize that disruption of the overall balance between vasodilatation and vasoconstriction in the kidney, during the early phase of sepsis, contribute to its (kidney) predisposition to acute renal failure. Adult male Wistar rats were rendered endotoxemic at different time points (1, 3, 6 and 10 h) by a single i.p. injection of lipopolysaccharide (LPS) (15 mg/kg) dissolved in saline. Control group was injected vehicle only (saline). Both systolic and diastolic blood pressures significantly decreased at different time points after LPS administration. Surprisingly, renal histopathological evaluation showed no remarkable changes in LPS-induced endotoxemia. However, overall, levels of the vaso-regulators and, where applicable, their respective receptors were upregulated: (1) plasma ET-1 increased 25-fold and peaked, as renal ET-1 mRNA, at 3 h; renal ET-1 protein and its receptors, ET type A (ET(A)) receptor (vasoconstrictive) and ET type B (ET(B)) receptor (vasodilatatory) increased in a time-dependent fashion, (2) Ang II increased by 53% compared to control, peaking at 6 h. However, while levels of Ang II type 1 (AT1) receptor increased over time after LPS injection, those of Ang II type 2 (AT2) receptor were downregulated, (3) data of NO system (NO-NOS), the key vasodilator, were the most intriguing. Whereas levels of renal NO increased time-dependently following LPS administration, with a 2240-fold increase in renal iNOS expression, levels of eNOS, were almost unchanged. In conclusion, the present study overall reveals intriguing and complex dynamics between levels of vasoconstrictors and vasodilators during the early phase of LPS-induced endotoxemia. These shifts in molecular expressions are likely triggered by compensatory mechanisms aimed at counteracting the undesirable and dominant effects of one group of vaso-regulatory moiety over the other.
机译:为了阐明内毒素血症期间以肾血管收缩和全身性低血压/全身性非肾血管扩张为特征的内毒素血症肾并发症的发病机制中微血管因子的作用,我们分析了三种主要血管调节剂即内皮素( ET)-1,一氧化氮(NO)和血管紧张素II(Ang II)。我们假设败血症的早期阶段,肾脏血管舒张和血管收缩之间总体平衡的破坏会导致其(肾脏)易患急性肾功能衰竭。成年雄性Wistar大鼠通过一次腹膜内注射在不同时间点(1、3、6和10小时)内毒素血症。注射溶于盐水的脂多糖(LPS)(15 mg / kg)。对照组仅注射媒介物(盐水)。 LPS给药后不同时间点的收缩压和舒张压均显着降低。令人惊讶的是,肾脏组织病理学评估显示,LPS诱导的内毒素血症无明显变化。然而,总体而言,血管调节剂的水平以及(如果适用)它们各自的受体的水平被上调:(1)血浆ET-1增加25倍,并在3小时达到肾ET-1 mRNA的峰值;肾脏ET-1蛋白及其受体,ET A型(ET(A))受体(血管收缩)和ET B型(ET(B))受体(血管舒张)以时间依赖性方式增加,(2)Ang II增加与对照组相比,降低了53%,在6小时达到峰值。然而,虽然在注射LPS后Ang II 1型(AT1)受体水平随时间增加,但Ang II 2型(AT2)受体水平却被下调。(3)关键血管舒张剂NO系统(NO-NOS)的数据,是最有趣的LPS给药后,肾脏NO水平随时间增加,肾脏iNOS表达增加2240倍,而eNOS水平几乎没有变化。总而言之,本研究总体上揭示了LPS诱导的内毒素血症早期阶段中血管收缩剂和血管舒张剂水平之间有趣而复杂的动态。分子表达的这些变化可能是由旨在抵消一组血管调节部分相对于另一组的不良和显性作用的补偿机制触发的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号